Hospitals fight drug scarcity, fear patients harmed
The growing scarcity of sterile, injectable drugs is one of the biggest issues confronting hospitals across the country, and will be a key issue at the annual American Society of Clinical Oncology meeting in Chicago this weekend. Health officials blame the shortages on industry consolidation that has left only a handful of generic manufacturers of these drugs, even as the number of drugs going off-patent is growing. Some drugmakers have been plagued by manufacturing problems that have shut down multiple plants or production lines, while others have stopped producing a treatment when profit margins erode too far.
- mHealth Tackles Readmissions
- CNO Leads $1M Charge for New Scrubs, Uniforms
- 'Kafkaesque' Value System Unfairly Penalizes Doctor Pay
- Targeting Self-Insured Populations
- MA an Insurance Proving Ground for Providers
- Sharp HealthCare Leaves Pioneer ACO Program
- Some Cancer Hospitals' Quality Data Will Soon Be Public
- Docs Fret as HHS Addresses Malpractice Reporting 'Loopholes'
- Proton Beam Therapy Poised for Growth in US
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013